Erratum: Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy (Journal of Medical Genetics (2016) 53, (511-22) DOI: 10.1136/jmedgenet-2015-103451);Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy

Journal of Medical Genetics

Volumn 53, Issue 8, 2016, Pages 511-522

  Mignot, Cyril ^a,b,c   von Stülpnage, Celina ^a,d,e   Nava, Caroline ^a,c   Ville, Dorothée ^f   Sanlaville, Damien ^f,g,h   Lesca, Gaetan ^f,g,h   Rastetter, Agnès ^c   Gachet, Benoit ^c   Marie, Yannick ^c   Korenke, G Christoph ⁱ   Borggraefe, Ingo ^j   Hoffmann Zacharska, Dorota ^k   Szczepanik, Elzbieta ^k   Rudzka Dybala, Mariola ^k   Yiş, Uluç ^l   Çağlayan, Hande ^m   Isapof, Arnaud ⁿ   Marey, Isabelle ^a   Panagiotakaki, Eleni ^o   Korff, Christian ^p   Rossier, Eva ^q   Riess, Angelika ^q   Beck Woedl, Stefanie ^q   Rauch, Anita ^r   Zweier, Christiane ^s   Hoyer, Juliane ^s   Reis, André ^s   Mironov, Mikhail ^t   Bobylova, Maria ^t   Mukhin, Konstantin ^t   Hernandez Hernandez, Laura ^u   Maher, Bridget ^u   Sisodiya, Sanjay ^u   Kuhn, Marius ^v   Glaeser, Dieter ^v   Wechuysen, Sarah ^c,w   Myers, Candace T ^x   Mefford, Heather C ^x   Hörtnagel, Konstanze ^y   Biskup, Saskia ^y   Lemke, Johannes R ^z   Héron, Delphine ^a,b,c,d   Kluger, Gerhard ^d,e   Depienne, Christel ^a,c   Craiu, Dana ^aa,ab   De Jonghe, Peter ^w   Helbig, Ingo ^ac,ad   Guerrini, Renzo ^ae   Lehesjoki, Anna Elina ^af,ag   Marini, Carla ^ae   Muhle, Hiltrud ^ad   Møller, Rikke S ^ah   Neubauer, Bernd ^ai   Pal, Deb ^aj   Selmer, Kaja ^ak   Stephani, Ulrich ^ah   Sterbova, Katalin ^al   Striano, Pasquale ^am   Talvik, Tiina ^an,ao   von Spiczak, Sarah ^ad   more..

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Centre de Rèfèrence 'dè Ficiences Intellectuelles de Causes Rares   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d Hospital for Neuropediatrics and Neurological Rehabilitation   (Germany)

^e PARACELSUS MEDICAL UNIVERSITY   (Austria)

^f HOSPICES CIVILS DE LYON   (France)

^g UNIVERSITÉ LYON 1   (France)

^h LYON NEUROSCIENCE RESEARCH CENTER   (France)

ⁱ UNIVERSITY OF OLDENBURG   (Germany)

^j UNIVERSITY OF MUNICH   (Germany)

^k INSTITUTE OF MOTHER AND CHILD   (Poland)

^l DOKUZ EYLUL UNIVERSITY   (Turkey)

^m BOGAZICI UNIVERSITY   (Turkey)

ⁿ ARMAND TROUSSEAU HOSPITAL   (France)

^o HFME   (France)

^p GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^q UNIVERSITY OF TÜBINGEN   (Germany)

^r UNIVERSITY OF ZURICH   (Switzerland)

^s UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^t Center of Child Neurology and Epilepsy   (Russian Federation)

^u UNIVERSITY COLLEGE LONDON   (United Kingdom)

^v Genetikum   (Germany)

^w DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^x UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^y CEGAT GMBH   (Germany)

^z UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^aa CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^ab Al Obregia Clinical Hospital   (Romania)

^ac CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^ad UNIVERSITY OF KIEL   (Germany)

^ae UNIVERSITY OF FLORENCE   (Italy)

^af FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^ag UNIVERSITY OF HELSINKI   (Finland)

^ah DANISH EPILEPSY CENTRE   (Denmark)

^ai JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^aj KING'S COLLEGE LONDON   (United Kingdom)

^ak OSLO UNIVERSITY HOSPITAL   (Norway)

^al UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^am G GASLINI INSTITUTE   (Italy)

^an UNIVERSITY OF TARTU   (Estonia)

^ao TARTU UNIVERSITY HOSPITAL   (Estonia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; AUTISM; BRAIN DISEASE; CHILD; CLINICAL ARTICLE; COGNITIVE DEFECT; DISEASE SEVERITY; EPILEPSY; EXON; FEMALE; GAIT DISORDER; GENE; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INTELLECTUAL IMPAIRMENT; MALE; MUSCLE HYPOTONIA; MYOCLONUS; MYOCLONUS SEIZURE; NEUROLOGIC EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SYNGAP1 GENE; YOUNG ADULT;

EID: 84981333011     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmedgenet-2015-103451corr1     Document Type: Erratum

References (39)

1. Kim JH, Liao D, Lau LF, Huganir RL. SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron 1998;20:683-91.
2. Chen HJ, Rojas-Soto M, Oguni A, Kennedy MB. A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. Neuron 1998;20:895-904.
3. Krapivinsky G, Medina I, Krapivinsky L, Gapon S, Clapham DE. SynGAP-MUPP1- CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. Neuron 2004;43:563-74.
4. Clement JP, Aceti M, Creson TK, Ozkan ED, Shi Y, Reish NJ, Almonte AG, Miller BH, Wiltgen BJ, Miller CA, Xu X, Rumbaugh G. Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell 2012;151:709-23.
5. Komiyama NH, Watabe AM, Carlisle HJ, Porter K, Charlesworth P, Monti J, Strathdee DJ, O'Carroll CM, Martin SJ, Morris RG, O'Dell TJ, Grant SG. SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J Neurosci 2002;22:9721-32.
6. Kim JH, Lee HK, Takamiya K, Huganir RL. The role of synaptic GTPase-activating protein in neuronal development and synaptic plasticity. J Neurosci 2003;23:1119-24.
7. Guo X, Hamilton PJ, Reish NJ, Sweatt JD, Miller CA, Rumbaugh G. Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia. Neuropsychopharmacology 2009;34:1659-72.
8. Muhia M, Yee BK, Feldon J, Markopoulos F, Knuesel I. Disruption of hippocampus-regulated behavioural and cognitive processes by heterozygous constitutive deletion of SynGAP. Eur J Neurosci 2010;31:529-43.
9. Aceti M, Creson TK, Vaissiere T, Rojas C, Huang WC, Wang YX, Petralia RS, Page DT, Miller CA, Rumbaugh G. Syngap1 haploinsufficiency damages a postnatal critical period of pyramidal cell structural maturation linked to cortical circuit assembly. Biol Psychiatry 2015;77:805-15.
10. McMahon AC, Barnett MW, O'Leary TS, Stoney PN, Collins MO, Papadia S, Choudhary JS, Komiyama NH, Grant SG, Hardingham GE, Wyllie DJ, Kind PC. SynGAP isoforms exert opposing effects on synaptic strength. Nat Commun 2012;3:900.
11. Vissers LE, de Ligt J, Gilissen C, Janssen I, Steehouwer M, de Vries P, van Lier B, Arts P, Wieskamp N, del Rosario M, van Bon BW, Hoischen A, de Vries BB, Brunner HG, Veltman JA. A de novo paradigm for mental retardation. Nat Genet 2010;42:1109-12.
12. Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, Albrecht B, Bartholdi D, Beygo J, Di Donato N, Dufke A, Cremer K, Hempel M, Horn D, Hoyer J, Joset P, Ropke A, Moog U, Riess A, Thiel CT, Tzschach A, Wiesener A, Wohlleber E, Zweier C, Ekici AB, Zink AM, Rump A, Meisinger C, Grallert H, Sticht H, Schenck A, Engels H, Rappold G, Schrock E, Wieacker P, Riess O, Meitinger T, Reis A, Strom TM. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 2012;380:1674-82.
13. de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, Gilissen C, del Rosario M, Hoischen A, Scheffer H, de Vries BB, Brunner HG, Veltman JA, Vissers LE. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 2012;367:1921-9.
14. Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR. De novo mutations in epileptic encephalopathies. Nature 2013;501:217-21.
15. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, O'Dushlaine C, Chambert K, Bergen SE, Kahler A, Duncan L, Stahl E, Genovese G, Fernandez E, Collins MO, Komiyama NH, Choudhary JS, Magnusson PK, Banks E, Shakir K, Garimella K, Fennell T, DePristo M, Grant SG, Haggarty SJ, Gabriel S, Scolnick EM, Lander ES, Hultman CM, Sullivan PF, McCarroll SA, Sklar P. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 2014;506:185-90.
16. Hamdan FF, Gauthier J, Spiegelman D, Noreau A, Yang Y, Pellerin S, Dobrzeniecka S, Cote M, Perreau-Linck E, Carmant L, D'Anjou G, Fombonne E, Addington AM, Rapoport JL, Delisi LE, Krebs MO, Mouaffak F, Joober R, Mottron L, Drapeau P, Marineau C, Lafreniere RG, Lacaille JC, Rouleau GA, Michaud JL. Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med 2009;360:599-605.
17. Hamdan FF, Gauthier J, Araki Y, Lin DT, Yoshizawa Y, Higashi K, Park AR, Spiegelman D, Dobrzeniecka S, Piton A, Tomitori H, Daoud H, Massicotte C, Henrion E, Diallo O, Shekarabi M, Marineau C, Shevell M, Maranda B, Mitchell G, Nadeau A, D'Anjou G, Vanasse M, Srour M, Lafreniere RG, Drapeau P, Lacaille JC, Kim E, Lee JR, Igarashi K, Huganir RL, Rouleau GA, Michaud JL. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet 2011;88:306-16.
18. Carvill GL, Heavin SB, Yendle SC, McMahon JM, O'Roak BJ, Cook J, Khan A, Dorschner MO, Weaver M, Calvert S, Malone S, Wallace G, Stanley T, Bye AM, Bleasel A, Howell KB, Kivity S, Mackay MT, Rodriguez-Casero V, Webster R, Korczyn A, Afawi Z, Zelnick N, Lerman-Sagie T, Lev D, Moller RS, Gill D, Andrade DM, Freeman JL, Sadleir LG, Shendure J, Berkovic SF, Scheffer IE, Mefford HC. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet 2013;45:825-30.
19. Redin C, Gérard B, Lauer J, Herenger Y, Muller J, Quartier A, Masurel-Paulet A, Willems M, Lesca G, El-Chehadeh S, Le Gras S, Vicaire S, Philipps M, Dumas M, Geoffroy V, Feger C, Haumesser N, Alembik Y, Barth M, Bonneau D, Colin E, Dollfus H, Doray B, Delrue MA, Drouin-Garraud V, Flori E, Fradin M, Francannet C, Goldenberg A, Lumbroso S, Mathieu-Dramard M, Martin-Coignard D, Lacombe D, Morin G, Polge A, Sukno S, Thauvin-Robinet C, Thevenon J, Doco-Fenzy M, Genevieve D, Sarda P, Edery P, Isidor B, Jost B, Olivier-Faivre L, Mandel JL, Piton A. Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing. J Med Genet 2014;51:724-36.
20. Berryer MH, Hamdan FF, Klitten LL, Moller RS, Carmant L, Schwartzentruber J, Patry L, Dobrzeniecka S, Rochefort D, Neugnot-Cerioli M, Lacaille JC, Niu Z, Eng CM, Yang Y, Palardy S, Belhumeur C, Rouleau GA, Tommerup N, Immken L, Beauchamp MH, Patel GS, Majewski J, Tarnopolsky MA, Scheffzek K, Hjalgrim H, Michaud JL, Di Cristo G. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency. Hum Mutat 2013;34:385-94.
21. O'Roak BJ, Stessman HA, Boyle EA, Witherspoon KT, Martin B, Lee C, Vives L, Baker C, Hiatt JB, Nickerson DA, Bernier R, Shendure J, Eichler EE. Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nat Commun 2014;5:5595.
22. Hamdan FF, Daoud H, Piton A, Gauthier J, Dobrzeniecka S, Krebs MO, Joober R, Lacaille JC, Nadeau A, Milunsky JM, Wang Z, Carmant L, Mottron L, Beauchamp MH, Rouleau GA, Michaud JL. De Novo SYNGAP1 Mutations in Nonsyndromic Intellectual Disability and Autism. Biol Psychiatry 2011;69:898-901.
23. Parker MJ, Fryer AE, Shears DJ, Lachlan KL, McKee SA, Magee AC, Mohammed S, Vasudevan PC, Park SM, Benoit V, Lederer D, Maystadt I, FitzPatrick DR. De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability. Am J Med Genet A 2015;167A:2231-7.
24. von Stülpnagel C, Funke C, Haberl C, Hortnagel K, Jungling J, Weber YG, Staudt M, Kluger G. SYNGAP1 mutation in focal and generalized epilepsy: a literature overview and a case report with special aspects of the EEG. Neuropediatrics 2015;46:287-91.
25. Large-scale discovery of novel genetic causes of developmental disorders. Nature 2015;519:223-8.
26. Klitten LL, Møller RS, Nikanorova M, Silahtaroglu A, Hjalgrim H, Tommerup N. A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA). Epilepsia 2011;52:e190-3.
27. Krepischi AC, Rosenberg C, Costa SS, Crolla JA, Huang S, Vianna-Morgante AM. A novel de novo microdeletion spanning the SYNGAP1 gene on the short arm of chromosome 6 associated with mental retardation. Am J Med Genet A 2010;152A:2376-8.
28. Zollino M, Gurrieri F, Orteschi D, Marangi G, Leuzzi V, Neri G. Integrated analysis of clinical signs and literature data for the diagnosis and therapy of a previously undescribed 6p21.3 deletion syndrome. Eur J Hum Genet 2011;19:239-42.
29. Writzl K, Knegt AC. 6p21.3 microdeletion involving the SYNGAP1 gene in a patient with intellectual disability, seizures, and severe speech impairment. Am J Med Genet A 2013;161A:1682-5.
30. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, Almeida J, Bacchelli E, Bader GD, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, Bolte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Bryson SE, Carson AR, Casallo G, Casey J, Chung BH, Cochrane L, Corsello C, Crawford EL, Crossett A, Cytrynbaum C, Dawson G, de Jonge M, Delorme R, Drmic I, Duketis E, Duque F, Estes A, Farrar P, Fernandez BA, Folstein SE, Fombonne E, Freitag CM, Gilbert J, Gillberg C, Glessner JT, Goldberg J, Green A, Green J, Guter SJ, Hakonarson H, Heron EA, Hill M, Holt R, Howe JL, Hughes G, Hus V, Igliozzi R, Kim C, Klauck SM, Kolevzon A, Korvatska O, Kustanovich V, Lajonchere CM, Lamb JA, Laskawiec M, Leboyer M, Le Couteur A, Leventhal BL, Lionel AC, Liu XQ, Lord C, Lotspeich L, Lund SC, Maestrini E, Mahoney W, Mantoulan C, Marshall CR, McConachie H, McDougle CJ, McGrath J, McMahon WM, Merikangas A, Migita O, Minshew NJ, Mirza GK, Munson J, Nelson SF, Noakes C, Noor A, Nygren G, Oliveira G, Papanikolaou K, Parr JR, Parrini B, Paton T, Pickles A, Pilorge M, Piven J, Ponting CP, Posey DJ, Poustka A, Poustka F, Prasad A, Ragoussis J, Renshaw K, Rickaby J, Roberts W, Roeder K, Roge B, Rutter ML, Bierut LJ, Rice JP, Salt J, Sansom K, Sato D, Segurado R, Sequeira AF, Senman L, Shah N, Sheffield VC, Soorya L, Sousa I, Stein O, Sykes N, Stoppioni V, Strawbridge C, Tancredi R, Tansey K, Thiruvahindrapduram B, Thompson AP, Thomson S, Tryfon A, Tsiantis J, Van Engeland H, Vincent JB, Volkmar F, Wallace S, Wang K, Wang Z, Wassink TH, Webber C, Weksberg R, Wing K, Wittemeyer K, Wood S, Wu J, Yaspan BL, Zurawiecki D, Zwaigenbaum L, Buxbaum JD, Cantor RM, Cook EH, Coon H, Cuccaro ML, Devlin B, Ennis S, Gallagher L, Geschwind DH, Gill M, Haines JL, Hallmayer J, Miller J, Monaco AP, Nurnberger JI Jr, Paterson AD, Pericak-Vance MA, Schellenberg GD, Szatmari P, Vicente AM, Vieland VJ, Wijsman EM, Scherer SW, Sutcliffe JS, Betancur C. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010;466:368-72.
31. Nava C, Dalle C, Rastetter A, Striano P, de Kovel CG, Nabbout R, Cances C, Ville D, Brilstra EH, Gobbi G, Raffo E, Bouteiller D, Marie Y, Trouillard O, Robbiano A, Keren B, Agher D, Roze E, Lesage S, Nicolas A, Brice A, Baulac M, Vogt C, El Hajj N, Schneider E, Suls A, Weckhuysen S, Gormley P, Lehesjoki AE, De Jonghe P, Helbig I, Baulac S, Zara F, Koeleman BP, Euro ERESC, Haaf T, LeGuern E, Depienne C. De novo mutations in HCN1 cause early infantile epileptic encephalopathy. Nat Genet 2014;46:640-5.
32. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010;26:589-95.
33. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010;20:1297-303.
34. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshe SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51:676-85.
35. Quirk JA, Fish DR, Smith SJ, Sander JW, Shorvon SD, Allen PJ. First seizures associated with playing electronic screen games: a community-based study in Great Britain. Ann Neurol 1995;37:733-7.
36. Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F, Coleman M, Leboyer M, Gillberg C, Bourgeron T. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet 2010;26:363-72.
37. Ebert DH, Greenberg ME. Activity-dependent neuronal signalling and autism spectrum disorder. Nature 2013;493:327-37.
38. Berger JM, Rohn TT, Oxford JT. Autism as the early closure of a neuroplastic critical period normally seen in adolescence. Biol Syst Open Access 2013;1:1-15.
39. Meredith RM. Sensitive and critical periods during neurotypical and aberrant neurodevelopment: a framework for neurodevelopmental disorders. Neurosci Biobehav Rev 2015;50:180-8.